Biolex Therapeutics

closed

Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.

HQ location

Pittsboro, United States

Website

Launch date

1997

Employees

Enterprise value

$80—120m

Recent deals

https://www.linkedin.com/company/biolex/

Get premium to view all results

Date	Investors	Amount	Round
-	investor	€0.0	round
Jan 1997	investor	€0.0	round
Aug 2003	investor investor	€0.0	round
Jan 2005	N/A	€0.0	round
Sep 2005	investor investor investor investor investor	€0.0	round
May 2007	investor	€0.0	round
Oct 2008	N/A	€0.0	round
Feb 2010	N/A	€0.0	round
Oct 2010	N/A	€0.0	round
Jun 2011	N/A	€0.0	round
Dec 2011	N/A	$2.4m	Debt
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads

Epicyte Pharmaceuticals

ACQUISITION by Biolex Therapeutics May 2004

ACQUISITION by Biolex Therapeutics Jul 2005